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ABSTRACT 
Objective. The aim of this study was 
to investigate, using ultrasound (US), 
knee involvement in patients with Beh-
çet’s disease (BD). 
Methods. Knee US was performed in 30 
unselected Italian BD patients. Signs of 
arthritis (joint effusion, synovial prolif-
eration) and presence of  bone erosions 
and Baker’s cysts were recorded. Pow-
er Doppler evaluation was performed. 
A semi-quantitative score was used 
for each structure examined, whereby 
0 was to indicate the absence of any 
change and score from 1 to 3 the pres-
ence of mild to severe changes. A sum of 
the single scores was obtained. Disease 
activity was evaluated to identify the 
correlation with the US modifi cations.
Results. Twenty (66.6%) patients had 
symptomatic articular involvement 
and US showed knee involvement in 
18 of them (60%). Synovial prolifera-
tion was detected in 14 (46%, positive 
power Doppler in 4),  joint effusion  in 
14 (46%), bone surface erosions in 3 
(10%). Four patients, asymptomatic 
for joint involvement, showed US alter-
ations. Eleven patients showed a total 
score between 1 and 3, while the other 
7 had a score between 4 and 6. Sub-
jects with a higher US score presented 
an increased prevalence of  acneiform 
skin lesions with respect to the group 
with US score 1-3. Statistical analysis 
showed a positive correlation between 
disease activity and US score in group 
2 (p=0.04).
Conclusion. This study confi rms that 
peripheral joint involvement represents 
an important clinical aspect in italian 
BD patients and US evaluation is useful 
for the detection of  this aspect. 
Introduction
Behçet’s disease (BD) is a multi-sys-
temic infl ammatory disorder of uncer-
tain aethiopathogenesis, now classi-
fi ed as a vasculitis. It is uncommon in 
western Europe and USA, being much 
more prevalent in eastern Mediterra-
nean countries, South East Asia and Ja-
pan, following the so-called “old silk-
route”. Young onset (before the age of 
25) and male sex represent risk factors 
for a more severe disease. The clinical 
spectrum of BD is wide and includes 
muco-cutaneous manifestations such 
as oral and genital aphthous ulcera-
tions, skin follicolitis and erythema 
nodosum, eye disease with posterior 
uveitis and retinal vasculitis, articular, 
gastrointestinal, cardiovascular, renal, 
pulmonary, and central nervous system 
involvement (1, 2). 
Traditionally, clinical manifestations of 
BD have been divided into major and 
minor, according to their prevalence 
(3). Even if vasculitic lesions, neuro-
logical involvement and arthritis are 
classifi ed as ‘minor’, their relevance in 
terms of prognosis ”quod vitam et quod 
valitudinem” should not be overlooked. 
In fact, vasculitis and brain complica-
tions may be clinically severe and even 
life-threatening and arthritis is one of 
the most frequent clinical features of 
the disease sometimes being destructive 
(4-7).
Within the past decade, musculoskel-
etal ultrasound (US) has become an 
established imaging technique for the 
diagnosis and follow-up of patients with 
rheumatic diseases and improved mus-
culoskeletal imaging in rheumatology 
(8-12). 
As far as we know, US has never been 
used to assess peripheral joint involve-
ment in BD patients. The aim of this 
study has been to investigate, using US, 
knee involvement in patients with BD.
The knee has been selected because it 
is often involved in BD and it is a joint 
reliably studied by US (13-15).
Patients and methods
Thirty unselected Italian patients with 
BD have been studied, 9 women and 
21 men with a mean age of 45 years 
(range 20-69 years) and an average dis-
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ease duration of 8.5 years (range 2-21 
years). The diagnosis was formulated 
according to International Study Group 
Criteria (16).
Glucocorticoids were used in 63.3% of 
patients with BD, immunosuppressive 
drugs (cyclosporine A, methotrexate, 
azathioprine) in 56.6%, infl iximab in 
13%. Four patients were in complete 
remission and did not receive therapy. 
Disease activity in BD is diffi cult to 
defi ne because of the wide spectrum of 
symptoms which can vary enormously 
among patients and fl uctuate in the same 
patients over time. Moreover, there are 
no laboratory indices useful for refl ect-
ing clinical activity. Finally, important 
differences exist among ethnic groups 
regarding the prevalence and the sever-
ity of clinical manifestations. None of 
the previous disease activity scoring sys-
tems available for BD has been formally 
translated into Italian, nor has it had a 
cross-cultural validation in Italy. There-
fore, we considered active those patients 
with worsening of clinical symptoms at 
the time of the present investigation who 
manifested two out of the following 
fi ndings (oral and genital ulcerations, 
skin lesions, eye involvement, positive 
pathergy test, thrombophlebitis and ar-
thritis), or multiple erythema nodosum 
with severe infl ammation and with both 
elevated erythrocyte sedimentation rate 
and positive C-reactive protein (17). 
According to these criteria, 33.3% of 
patients had active disease. 
US examination
All the patients were submitted to US 
of both knees. US examination was 
performed by a rheumatologist who 
was experienced in US scanning, us-
ing a Philips/HP Image Point HX 
machine with a 10MHz linear probe. 
Power Doppler (PD) was used with the 
following settings: PRF 1000Hz gain 
18-30dB, low fi lter. The operator was 
blinded to the clinical and laboratory 
fi ndings in all cases. 
The knee was examined with the patient 
in supine position, performing both 
transverse and longitudinal scans of 
the supra patellar region and the lateral 
and medial recesses, according to EU-
LAR guidelines for US (13). An arbi-
trary scoring system ranging from 0 to 
14 for the assessment of knee involve-
ment was applied. Sonographic signs 
of synovitis (joint effusion, synovial 
hypertrophy) were recorded assigning 
a partial score (0 for the absence, 1 to 
3 according to severity); the presence 
of erosions of the bone surface was 
scored according to their number (1-2 
erosions: score 1; 3-4 erosions: score 2; 
more than 4 erosions: score 3; absence 
of erosions: score 0); a score of 0 was 
assigned in the absence of Baker’s cyst 
while the score was 1 in its presence. 
PD evaluation was performed for the 
analysis of vascularization of the syno-
vial membrane with a scoring system 
ranging from 0 to 3.
Statistical analysis
Fisher’s exact test was used to evaluate 
the presence of correlations between 
clinical features, disease activity and 
US modifi cations in BD patients. P 
values less than 0.05 were considered 
statistically signifi cant.
Results
Clinical features of BD patients are 
summarized in Table I. Twenty out of 
30 patients (66.6%) had symptomatic 
articular involvement: 8/30 (26.6%) 
have arthralgias and 12/30 (40%) have 
arthritis, with involvement of differ-
ent joints. Seven patients showed knee 
arthritis and the effusion was detect-
able during the physical examination.
In 18/30 patients (60%) knee US as-
sessment demonstrated signifi cant ab-
normalities. The highest value of US 
score recorded in this cohort of patients 
Table I. Main clinical features of 30 Behçet 
patients.
Clinical features Patients (n/%)
HLA-B51 allele 22 (73.3%)
Symptomatic articular 20 (66.6%)
     involvement
Aphtosis oral and/or genital 30 (100%)
Skin manifestations 20 (66.6%)
Ocular manifestations 25 (83.3%)
Nervous systems involvement   5 (16.6%)
Vascular manifestations 5 (16.6%)
Table II. US modifi cations in 30 Behçet 
patients. 
US modifi cations Patients (n/%)
Synovial proliferation 14 (46.6%)
Power Doppler positivity 4 (13.3%)
Joint effusion 13 (43.3%)
Erosions of bone surface 3 (10%)
Baker’s cyst 1 (3.3%)
Fig. 1. Suprapatellar transverse scan knee joint: presence of joint effusion (*) and synovial prolifera-
tion (◆).
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was 6. In particular, joint effusion was 
demonstrated in 14/30 (46%) as well as 
synovial proliferation (46%, with posi-
tivity of PD in 4/18, i.e., 28%) Bone 
surface erosions were present in 3/30 
(10%). Only one had a Baker’s cyst. 
(Table II) (Fig. 1).
Interestingly, 4 patients asymptomatic 
for joint involvement showed US alter-
ations (synovial proliferation in 4, joint 
effusion in 2). 
Subgrouping these patients according 
to the score point (group 1 score 1-3, 
group 2 core 4-6), 11 patients were in-
cluded in group 1, and 7 in group 2 (Fig. 
2). Skin manifestations prevailed in the 
group with a higher score in comparison 
to group 1 (7/7 (100%) vs. 4/11 (36.3). 
Twenty-two out of 30 patients had 
HLA-B51 allele; 13 out of 18 (72%) 
of patients with US modifi cations had 
HLA B51 vs. 9 out of 12 (75%) without 
sonographic knee involvement. 
No correlation was found between the 
kind of therapeutic approach and joint 
involvement (clinical symptoms and/or 
the degree of changes recorded by US). 
Statystical analysis showed a positive 
correlation between disease activity and 
US score in the group 2 (p = 0.04).
Discussion
Joint involvement has not been included 
in any of the presently available classi-
fi cation criteria for BD. However, it oc-
curs in 40-70% of patients, representing 
the fi rst symptom in 18-34.5% of cases, 
while in 9% it is the only one (18, 19).
The arthritis of BD is usually intermit-
tent, self-limited, not deforming (20) 
and an erosive arthropathy has been 
only rarely reported (6, 7).
In two large studies involving respec-
tively 309 and 340 cases of BD patients 
with joint manifestations, monoarthri-
tis, oligoarthritis and polyarthritis were 
seen in 12-17%, in 11.7-13.5%, and in 
17%-19.8% of cases respectively (18). 
Children are more likely than adults to 
have joint manifestations and polyar-
thritis (21).
Monoarthritis and oligoarthritis affect 
essentially knees and ankles, with a 
marked male bias. They usually run an 
acute or recurrent course, with chronic 
forms being rare. Synovial fl uid exami-
nation during acute attacks reveals in-
fl ammatory fl uid, with increased viscos-
ity and number of leukocytes (between 
5000 and 50.000, with PMN predomi-
nancy) and normal protein and glucose 
levels (22).
Polyarthritis generally involves the 
large limb joints and the small joints 
of the hands and feet. Unusual forms 
include arthritis with deformities and/
or destruction, pseudogout, rupture of 
popliteal cyst and myositis (18, 19).Ac-
neiform skin lesions (papules and pus-
tules) seem to be more frequent in pa-
tients with BD with joint involvement 
and some authors have suggested that 
the arthritis seen in BD may possibly 
be related to acne associated arthritis 
(23). BD is rarely associated with rheu-
matoid arthritis, Sjögren’s syndrome, 
systemic lupus erythematosus, relaps-
ing polychondritis and amyloidosis, 
while the most frequently described as-
sociation is with seronegative spondy-
loarthropathies. The inclusion of BD in 
the spondyloarthropathy (SpA) com-
plex is still debatable. Several patients 
with coexisting AS and BD have been 
described in the literature (24-28) and 
some authors have found a high preva-
lence of AS or SI in patients with BD 
(29-31). Different ethnicity of BD pa-
tients, etherogeneity in the criteria se-
lected for BD classifi cation as well as 
observer variation in interpreting the 
radiographic result of anteroposterior 
view of the pelvis or the lack of appro-
priate control groups are all possible 
reasons for these discrepancies. 
Several studies have dimostrated that 
high frequency US is accurate for de-
tecting joint effusion and synovitis, 
even compared with magnetic reso-
nance imaging (MRI) and direct ar-
throscopy visualisation (32-37) and 
over the last few years US has become 
an established imaging technique for 
the diagnosis and follow-up of patients 
with rheumatic diseases (9-12, 38). 
This conclusion has been based mainly 
on the visualisation of infl ammatory 
and/or destructive joint changes that 
were not detected by clinical and ra-
diographic examination (39).
US is most commonly used in the as-
sesment of soft tissue diseases (particu-
larly hypertrophy of the synovial mem-
brane, tenosynovitis, bursitis) or detec-
tion of fl uid collection and can also be 
used to visualise other structures, such 
as cartilage and bone surfaces (particu-
larly presence of erosions).
PD US is a new technique of colour 
Doppler that improves the sensitivity 
to detect fl ow from small vessels and 
low velocitiy fl ow in microvascular 
level. PD US detects indirect signs 
of increased vascularisation associ-
ated with soft tissue infl ammatory and 
infectious diseases and enthesitis in 
spondyloarthropathies. PD signal cor-
relates highly with local clinical evalu-
ation of joint infl ammatory activity in 
the knee, metacarpophalangeal and 
interphalangeal joints in rheumatoid 
arthritis patients (40-43).
Effusion and synovial proliferation are 
considered the US characteristics of 
synovitis. In fact, synovial infl amma-
tion is characterized by hyperthrophic 
changes with angiogenesis, synovial 
cell hyperplasia and joint effusion (14).
As far as we know, this is the fi rst study 
focused on the assessment of peripher-
al knee arthritis in BD with US, dem-
onstrating a high prevalence of signs 
of synovitis. Most of our patients had 
a low US score confi rming that in BD 
joint involvement is mild and parallels 
Fig. 2. US score 
distribution.
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general disease activity.
However, an erosive form was detected 
in 10% of the patients suggesting that 
also bone surface can be affected in BD. 
Interestingly, some patients asympto-
matic for joint involvement showed 
US alterations. This fi nding confi rms 
the high sensitivity of US in the detec-
tion of joint alterations in rheumatic 
diseases (8-11, 44). Acneiform skin 
lesions (papules and pustules) seem to 
be more frequent in patients with joint 
involvement as detected by US and this 
confi rms some previous clinical obser-
vations about the increased prevalence 
of joint involvement in patients with 
follicolitis (22, 39, 40).
Even though this study was limited to 
the evaluation of a single joint, it con-
fi rms that articular involvement repre-
sents an important clinical feature in 
Italian patients with BD. US evaluation 
allows the study of this aspect, identi-
fying the presence of synovitis signs 
also in patients with a negative clinical 
picture. 
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